Taiwan Emerges as Critical Unspoken Issue in TrumpXi Talks Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Skills Over Diplomas The Shift in EntryLevel Hiring Reshapes Talent Strategies European AI Stocks Surge Over 100 in Blockbuster Rally This Year Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Among Key Investor Items in CNBC Morning Squawk Wingstop Shares Drop 12 as Quarterly Profit Misses Analyst Expectations LUXE Q1 2026 Earnings EPS Misses Estimates by 2253 as Stock Edges Lower GAIA Q1 2026 Earnings Loss Narrowly Misses Estimates Shares Rise on Strategic Progress KKRT Q1 2026 Earnings Strong EPS Surprise of 657 Signals Underlying Strength for KKR Subordinated Notes POR Q1 2026 Earnings EPS Misses Estimates by 346 as Cost Pressures Mount YDKG Q4 2012 Earnings EPS Misses Estimates by 1422 as Stock Gains 458 BCE Inc BCE Rallies Slightly Support and Resistance Levels in Focus NMFC Slips 1 as Price Tests Key Support Levels Reinsurance Group of America RGA Pulls Back Support Levels in Focus After 25 Decline AMTD Digital HKD Nears Key Support as Slight Decline Continues Marzetti Company MZTI Holds Near 114 as Slight Loss Reflects Cautious Trading UK Spy Chief Warns of Growing Threats From Russia and China Geopolitical Risks Loom for Global Markets Selective Insurance Group SIGIP Q1 2026 Earnings EPS Misses Estimates by Nearly 11 Stock Edges Lower Fate Therapeutics Surges Over 10 as Biotech Sector Shows Signs of Life FATE MBI Q1 2026 Earnings Significant EPS Miss Reflects Continued Headwinds KEP Q4 2025 Earnings EPS Misses Estimates Amid Cost Pressures Stock Slips ADAMZ Q1 2026 Earnings Strong EPS Beat Despite Slight Stock Decline ARVN Q1 2026 Earnings EPS Beats Expectations as Pipeline Advances Without Revenue Ziff Davis Q1 2026 Earnings EPS Misses Estimates Stock Rises 475 PhenixFIN Corporation 525 Notes due 2028 PFXNZ Q1 2026 Earnings Strong EPS Beat of 2541 Surprise Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress